Skip to main content
    S

    Sutro Biopharma (STRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $8.92
    -0.40 (-4.29%)

    Market Cap: $154.72M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Sutro Biopharma (STRO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Sutro Biopharma (STRO) has a latest price of $8.92 on Nov 17, 2026, 79.7% below its 52-week high of $43.85. Its price fell 1.4% over the past 12 months. The month-end price fell 93.9% since Sep 2018, a compound annual decline of 29.3%.

    Price Chart

    From Sep 2018 to Oct 2026, its highest month-end close was $227.60 in Mar 2021 and its lowest $6.51 in Mar 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart STRO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for STRO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 59.3%, and over 6 months it fell 71.8%. The month-end price fell 66.9% over the 3 years through Oct 2026, a compound annual decline of 30.8%.

    PeriodChange
    1 month-20.7%
    3 months-59.3%
    6 months-71.8%
    12 months-1.4%
    12 months, with dividends-1.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-66.9%-30.8%
    5 years-95.5%-46.2%
    Since Sep 2018-93.9%-29.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 97.4%, and its weakest was 2024, when it fell 57.1%.

    YearCloseChange
    2026 through Oct 2026$9.10-21.3%
    2025$11.57-37.1%
    2024$18.40-57.1%
    2023$42.90-46.9%
    2022$80.80-45.7%
    2021$148.80-31.5%
    2020$217.10+97.4%
    2019$110.00+22.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 30.1% below its 50-day average of $12.76 and 60.7% below its 200-day average of $22.70.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$8.92
    52-week high$43.85-79.7%
    52-week low$7.15+24.8%
    50-day average$12.76-30.1%
    200-day average$22.70-60.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 90.7%.

    MeasureValue
    1-year beta1.54
    Largest fall, 1 year-78.3%
    Largest fall, 3 years-90.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About STRO

    What is STRO's 1-year price change?

    Sutro Biopharma's price fell 1.4% over the past 12 months. With dividends included, the 12-month total return was -1.4%.

    What is STRO's 5-year price change?

    Sutro Biopharma's month-end price fell 95.5% over the 5 years through Oct 2026, a compound annual decline of 46.2%. These figures leave out dividends.

    What is STRO's 52-week high and low?

    Sutro Biopharma's 52-week high is $43.85 and its 52-week low is $7.15. Its latest price of $8.92 on Nov 17, 2026 is 79.7% below the high.

    What is STRO's beta?

    Sutro Biopharma's 1-year beta against the S&P 500 is 1.54, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 78.3%.

    Is the STRO chart free?

    Yes. Advanced Charting for STRO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.